Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TRISENOX DIN 02480387

Status: Cancelled Post Market
Holder: TEVA CANADA LIMITED
Molecule: ARSENIC TRIOXIDE

Health Canada record

Active ingredient(s)ARSENIC TRIOXIDE 12 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCL01XX27 ARSENIC TRIOXIDE
Original market date16-Apr-2020
Current status date18-Apr-2023
SourceHealth Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ARSENIC TRIOXIDE

DINProductCompanyFormStrengthStatus
02513420ARSENIC TRIOXIDE FOR INJECTIONSANDOZ CANADA INCORPORATEDSolutionARSENIC TRIOXIDE 10 MGMarketed
02554364ARSENIC TRIOXIDE FOR INJECTIONMARCAN PHARMACEUTICALS INCSolutionARSENIC TRIOXIDE 1 MGMarketed
02541971ARSENIC TRIOXIDE FOR INJECTIONEUGIA PHARMA INC.SolutionARSENIC TRIOXIDE 2 MGApproved
02540517ARSENIC TRIOXIDE FOR INJECTIONAURO PHARMA INCSolutionARSENIC TRIOXIDE 2 MGApproved
02492768ARSENIC TRIOXIDE FOR INJECTIONSTERIMAX INCSolutionARSENIC TRIOXIDE 1 MGMarketed
02487357ARSENIC TRIOXIDE SOLUTION FOR INJECTIONPHEBRA PTY LTDSolutionARSENIC TRIOXIDE 10 MGMarketed
00718777ARSENICUM ALBUM 3CH-30CH GLOBULESBOIRON LABORATOIRESTabletARSENIC TRIOXIDE 3 CHCancelled Post Market
00226246HERBAMINEDR RECKEWEG AND COLiquidARSENIC TRIOXIDE 8 X; BELLADONNA 30 X; BRYONIA 12 X; CHARCOAL ACTIVATED 12 X; PITUITARY POSTERIOR 12 X; SODIUM SULFATE 30 X; WHITE HELLEBORE ROOT 30 X; ERIODICTYON 12 XCancelled Post Market
02484366TEVA-ARSENIC TRIOXIDE FOR INJECTIONTEVA CANADA LIMITEDSolutionARSENIC TRIOXIDE 12 MGCancelled Pre Market
02484358TEVA-ARSENIC TRIOXIDE FOR INJECTIONTEVA CANADA LIMITEDSolutionARSENIC TRIOXIDE 10 MGCancelled Pre Market
02407833TRISENOXTEVA CANADA LIMITEDSolutionARSENIC TRIOXIDE 10 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
212412018-08-24Supplement to a New Drug Submission (SNDS)NEW STRENGTH AND NEW DRUG PRODUCT MANUFACTURING SITE
212422018-08-24Supplement to a New Drug Submission (SNDS)ADDITION OF NEW STRENGTH TO THE P[RODUCT LABELLING

International API supply for ARSENIC TRIOXIDE

5 active FDA Drug Master Files.

Request a quote for TRISENOX

How to read a Canadian DIN record